Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 1711 AL 1725

Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis

Wu M, Li M, Yuan J, Liang S, Chen Z, Ye M, Ryan PM, Clark C, Tan SC, Rahmani J, Varkaneh HK, Bhagavathula AS.

Pharmacol Res. 2020 May;155:104693. doi: 10.1016/j.phrs.2020.104693. Epub 2020 Feb 11.

Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease

Jones JD, Rahmani E, Garcia E, Jacobs JP.

Parkinsonism Relat Disord. 2020 Mar;72:7-12. doi: 10.1016/j.parkreldis.2020.01.009. Epub 2020 Jan 25.

A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease

Ettcheto M, Busquets O, Espinosa-Jiménez T, Verdaguer E, Auladell C, Camins A.

Curr Pharm Des. 2020;26(12):1286-1299. doi: 10.2174/1381612826666200211121416.

Healthy Effects of Plant Polyphenols: Molecular Mechanisms

Leri M, Scuto M, Ontario ML, Calabrese V, Calabrese EJ, Bucciantini M, Stefani M.

Int J Mol Sci. 2020 Feb 13;21(4):1250. doi: 10.3390/ijms21041250.

Xenobiotics, Trace Metals and Genetics in the Pathogenesis of Tauopathies

Aaseth J, Buha A, Wallace DR, Bjørklund G.

Int J Environ Res Public Health. 2020 Feb 17;17(4):1269. doi: 10.3390/ijerph17041269.

Fibrinogen and risk of dementia: A systematic review and meta-analysis

Zhou Z, Liang Y, Zhang X, Xu J, Lin J, Zhang R, Kang K, Qu H, Zhao C, Zhao M.

Neurosci Biobehav Rev. 2020 May;112:353-360. doi: 10.1016/j.neubiorev.2020.02.022. Epub 2020 Feb 17.

PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape

Uzuegbunam BC, Librizzi D, Hooshyar Yousefi B.

Molecules. 2020 Feb 21;25(4):977. doi: 10.3390/molecules25040977.

Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease

Orgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I.

Cochrane Database Syst Rev. 2020 Feb 26;2(2):CD011961. doi: 10.1002/14651858.CD011961.pub2.

Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls

Jakimovski D, Bergsland N, Dwyer MG, Hagemeier J, Ramasamy DP, Szigeti K, Guttuso T, Lichter D, Hojnacki D, Weinstock-Guttman B, Benedict RHB, Zivadinov R.

Neurobiol Aging. 2020 Jun;90:84-92. doi: 10.1016/j.neurobiolaging.2020.02.002. Epub 2020 Feb 8.

Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology?

Kacířová M, Zmeškalová A, Kořínková L, Železná B, Kuneš J, Maletínská L.

Clin Sci (Lond). 2020 Mar 13;134(5):547-570. doi: 10.1042/CS20191313.

Brain insulin resistance: role in neurodegenerative disease and potential for targeting

Hölscher C.

Expert Opin Investig Drugs. 2020 Apr;29(4):333-348. doi: 10.1080/13543784.2020.1738383. Epub 2020 Mar 16.

The Influence of Vitamin D on Neurodegeneration and Neurological Disorders: A Rationale for its Physio-pathological Actions

Morello M, Pieri M, Zenobi R, Talamo A, Stephan D, Landel V, Féron F, Millet P.

Curr Pharm Des. 2020;26(21):2475-2491. doi: 10.2174/1381612826666200316145725.

Systematic review of gene expression studies in people with Lewy body dementia

Chowdhury A, Rajkumar AP.

Acta Neuropsychiatr. 2020 Dec;32(6):281-292. doi: 10.1017/neu.2020.13. Epub 2020 Mar 17.

Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitors

Ren SY, Wang ZZ, Zhang Y, Chen NH.

Acta Pharmacol Sin. 2020 Oct;41(10):1263-1271. doi: 10.1038/s41401-020-0385-7. Epub 2020 Mar 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias